STOCK TITAN

Bio-Techne to Present at Upcoming Investor Conferences

Bio-Techne (NASDAQ: TECH) will present at three investor conferences in early December 2025.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Bio-Techne (NASDAQ: TECH) will present at three investor conferences in early December 2025.

Events and times:

  • Evercore Healthcare Conference — December 2, 2025 at 8:20 AM ET
  • Citi Global Healthcare Conference — December 3, 2025 at 3:15 PM ET
  • Nasdaq Investor Conference — December 9, 2025 at 9:30 AM GMT

A live webcast of each presentation will be available via Bio-Techne's investor relations IR Calendar page: https://investors.bio-techne.com/ir-calendar.

Loading...
Loading translation...
Argus Nov 25 session
+3.72% close to close Open Argus
Details

News Market Reaction – TECH

On Nov 25, the day this news came out, TECH closed 3.72% above the previous close.

Data tracked by StockTitan Argus for the Nov 25 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MINNEAPOLIS, Nov. 25, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

8th Annual Evercore Healthcare Conference 2025
December 2, 2025
8:20 AM EST

Citi's 2025 Global Healthcare Conference
December 3, 2025
3:15 PM EST

53rd Annual Nasdaq Investor Conference
December 9, 2025
9:30 AM GMT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: LinkedIn, X or YouTube.

Contact:  David Clair, Vice President, Investor Relations & Corporate Development


david.clair@bio-techne.com

BT Logo (PRNewsfoto/Bio-Techne Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302625027.html

SOURCE Bio-Techne Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Bio-Techne (TECH) present at the Evercore Healthcare Conference?

Bio-Techne will present on December 2, 2025 at 8:20 AM ET.

How can investors watch Bio-Techne (TECH) presentations in December 2025?

Presentations will be available via a live webcast on Bio-Techne's IR Calendar page.

What time is Bio-Techne (TECH) scheduled to present at Citi's 2025 Global Healthcare Conference?

Bio-Techne is scheduled for December 3, 2025 at 3:15 PM ET.

When does Bio-Techne (TECH) present at the Nasdaq Investor Conference and what timezone is listed?

Bio-Techne will present on December 9, 2025 at 9:30 AM GMT.

Keep reading